PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |obesity |
| Sentences | 152 |
| PubMedID- 24782923 | obesity increases the risk of cardiovascular disease in adults, has been strongly associated with insulin resistance in nondiabetic persons and in individuals with type 2 diabetes [1, 2], and is considered as prerequisite for the diagnosis of metabolic syndrome (mets). |
| PubMedID- 23884162 | Background: in adults, obesity-driven inflammation can lead to increased cardiovascular disease (cvd). |
| PubMedID- 23525857 | (1) obesity increases the risk of cardiovascular diseases and type 2 diabetes mellitus, and accounts for a substantial proportion of global morbidity and mortality. |
| PubMedID- 23592673 | Objective: obesity often clusters with other major cardiovascular disease risk factors, yet a subset of the obese appears to be protected from these risks. |
| PubMedID- 23306192 | Also, obesity, a condition associated with cardiovascular disease [168], is associated with a lower vitamin d status due to a sequestration and volumetric dilution of the lipophilic vitamin d in the fat tissue [23,166,169,170], potentially explaining the described correlations [166]. |
| PubMedID- 24049653 | Association between the elevation in fibrinogen level and obesity increases the risk of cardiovascular disease [67]. |
| PubMedID- 23480970 | Objective: the obesity paradox in patients with cardiovascular disease (cvd) remains unexplained. |
| PubMedID- 25354500 | Overweight and grade i obesity in patients with cardiovascular disease: to treat or not to treat. |
| PubMedID- 23919019 | To adopt sts as a physical sign of underling high cardiac atherogenic factors and as a risk factor for cardiovascular disease, especially if associated with obesity and mets. |
| PubMedID- 24821545 | obesity increases the risk of cardiovascular disease in adults and has been strongly associated with insulin resistance in hyperglycemic people and those with type 2 diabetes [6]. |
| PubMedID- 21393118 | However, it is not clear whether cardiovascular disease is associated with abdominal obesity in dialysis patients. |
| PubMedID- 24073334 | It increases the severity of ischemic vascular diseases and, with obesity and type 2 diabetes, is one of the important risk factors for chronic kidney disease (ckd). |
| PubMedID- 23525430 | Background: obesity is closely associated with various cardiovascular diseases (cvds). |
| PubMedID- 22949997 | obesity is closely associated with diabetes, cardiovascular disease, metabolic syndrome, and other medical problems associated with increased mortality from disease [21]. |
| PubMedID- 24386004 | Diabetes is associated with various risk factors that may influence cognitive functioning, including diabetes-specific factors (e.g., hyperglycemia, insulin deficiency, and insulin resistance), vascular risk factors that are linked to diabetes (e.g., hypertension, hyperlipidemia, and obesity), and complications of (micro)vascular disease (e.g., stroke). |
| PubMedID- 24530764 | We aim to establish whether physical activity (pa) or less sedentary behaviour ameliorate associations of obesity with biomarkers for cardiovascular disease (cvd) and type 2 diabetes. |
| PubMedID- 21804638 | Several studies have confirmed a relationship between surrogate markers of future cardiovascular disease with childhood obesity, notably abdominal obesity, as well as with the degree of obesity. |
| PubMedID- 24885570 | Univariate and multivariate logistic regression were performed to analyze the associations between gender, older age, obesity, history of cardiovascular disease (cvd), smoking status, history of chronic pulmonary disease and history of cancer with presence of any incidental ct findings and, separately, pulmonary nodules. |
| PubMedID- 23866022 | A-fabp expression is known to be a key proinflammatory mediator that links obesity with cardiovascular disease. |
| PubMedID- 25726193 | Introduction: central obesity is specifically associated with cardiovascular disease. |
| PubMedID- 22137533 | In children and adolescents, obesity is associated with premature cardiovascular diseases, diabetes mellitus type 2, acanthosis nigricans, respiratory and skeletal muscle problems, as well as psychological problems. |
| PubMedID- 25676237 | If it can also be shown that levels of other inflammatory markers, plus adipokines and endothelial markers, are associated with excess body weight at similar ages in the life course, this would give additional support to the hypothesis that adipose tissue dysfunction is one of the pathways by which overweight and obesity lead to cardiovascular disease (cvd). |
| PubMedID- 24502884 | We aim to investigate whether insulin-sensitive obesity associates with prevalent cardiovascular diseases and 10-year coronary heart disease (chd) risk. |
| PubMedID- 25848853 | obesity is associated with increased cardiovascular disease risk and increased healthcare costs. |
| PubMedID- 24392111 | Periostin was further correlated with the development of cardiovascular disease associated with human obesity [8]. |
| PubMedID- 22745709 | This is surprising, given the positive associations of cardiovascular disease with obesity and stress exposure. |
| PubMedID- 22941940 | obesity is highly associated with dyslipidemia and cardiovascular disease. |
| PubMedID- 20660051 | Context: polycystic ovary syndrome (pcos) and obesity are associated with cardiovascular disease, but it is unclear to what extent they contribute independently. |
| PubMedID- 24642950 | It has been postulated that differences in metabolism between glucose and fructose may be a contributing factor to weight gain and obesity, and increased risk of cardiovascular disease and various metabolic conditions such as the metabolic syndrome and diabetes [25,26,27,28]. |
| PubMedID- 24823455 | Context: obstructive sleep apnea (osa) complicates morbid obesity and is associated with increased cardiovascular disease incidence. |
| PubMedID- 24731595 | De recherche (umr) 1048, obesity research laboratory, institute of metabolic and cardiovascular diseases, 31432 toulouse, france; university of toulouse, umr 1048, paul sabatier university, 31432 toulouse, france; toulouse university hospitals, department of clinical biochemistry, 31059 toulouse, france. |
| PubMedID- 23742964 | Background: current guidelines contain no advice on how to manage obesity and underweight in patients with peripheral vascular disease (pvd). |
| PubMedID- 21189275 | Introduction: obesity precedes the development of many cardiovascular disease risk factors, including type 2 diabetes mellitus (dm), hypertension, and chronic kidney disease. |
| PubMedID- 24704928 | obesity is associated with co-morbidities like cardiovascular diseases (cvd) and type 2 diabetes mellitus (t2dm), furthermore visceral obesity can be related to low testosterone (t) plasma levels. |
| PubMedID- 24410812 | Metabolic disturbances in obesity causes a number of diseases, namely, cardiovascular diseases (hypertension, atherosclerosis, coronary heart disease), stroke, insulin-dependent diabetes, premature death, diseases of musculoskeletal system (osteochondrosis and metabolic-dystrophic arthritis), hepatobiliary disease (gallbladder dyskinesia, chronic cholecystitis, cholelithiasis) and number of tumor sites, including lung cancer, breast cancer, uterine cancer and ovarian; in women, there is a violation of ovarian-menstrual cycle dyslipidemia. |
| PubMedID- 22145130 | Leptin is a 16 kda 167 amino acid polypeptide hormone and plays an important link between obesity and the development of cardiovascular disease. |
| PubMedID- 23983750 | [4] based on the available evidence, childhood obesity closely associates with cardiovascular diseases, hypertension, asthma, type 1 and 2 diabetes mellitus, increased insulin level, and orthopedic problems. |
| PubMedID- 24701431 | Childhood obesity is strongly associated with cardiovascular diseases, diabetes, orthopedic problems, mental disorders, non-alcoholic fatty liver disease and sleep-associated breathing disorders as they age. |
| PubMedID- 22508708 | Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. |
| PubMedID- 23630550 | The main obesity-related metabolic risk factors of cardiovascular disease involve low serum hdl cholesterol levels with increased levels of tg and ldl cholesterol levels. |
| PubMedID- 19832855 | Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in spain. |
| PubMedID- 24058506 | Moreover, obesity is strongly associated with cardiovascular disease, the leading cause of death worldwide and thus merits particular attention. |
| PubMedID- 21526994 | Background: obesity is commonly associated with diabetes, cardiovascular diseases and cancer. |
| PubMedID- 21586564 | Plasma resistin levels are elevated in obesity and are associated with metabolic and cardiovascular disease. |
| PubMedID- 22456541 | Recently, in a sample of 97 japanese individuals at high risk for cardiovascular disease with abdominal obesity, fasting serum glp-1 levels were found to be on average 28% higher in individuals with ms compared to those with pre-ms, and the glp-1 levels were elevated with increasing numbers of ms components or risk factors (46). |
| PubMedID- 23632233 | Association of obesity with cardiovascular disease mortality in the plco trial. |
| PubMedID- 20920244 | Conclusion: age and gender may influence the association of the insig2 obesity snp with pvd and cerebrovascular disease in patients with pre-existing cvd. |
| PubMedID- 24554346 | Other risk factors, such as age, dyslipidemia, obesity, family history of early cardiovascular diseases and smoking, were also recorded. |
| PubMedID- 26526941 | obesity is often associated with cardiovascular disease risk factors such as hypertension, dyslipoproteinemia, diabetes, and elevated inflammation markers [7–9]. |
| PubMedID- 19923378 | Background: in adults and adolescents, obesity is positively associated with cardiovascular disease risk factors; however, evidence in preschool children is scarce. |